Annual report pursuant to Section 13 and 15(d)

Derivative Contracts (Details 1)

v2.4.0.8
Derivative Contracts (Details 1) (Not Designated as Hedging Instrument [Member], USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Derivative Instruments, Gain (Loss) [Line Items]      
Total $ (36,489) $ 1,340 $ (39)
Pharmsynthez Notes Receivable and Purchase Option [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Total 1,936 0 0
Neovasc common stock options/warrants and BZNE Note conversion feature [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Total 4,608 1,350 (77)
Notes [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Total (43,082)      
Forward contracts [Member]
     
Derivative Instruments, Gain (Loss) [Line Items]      
Total $ 49 $ (10) $ 38